These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
363 related items for PubMed ID: 934580
1. Effect of bromo-ergocryptine on serum hPRL, hLH, hFSH, and estradiol 17-beta in women with galactorrhea-amenorrhea. Dickey RP, Stone SC. Obstet Gynecol; 1976 Jul; 48(1):84-9. PubMed ID: 934580 [Abstract] [Full Text] [Related]
2. Amenorrhea and galactorrhea: results of therapy with 2-Brom-alpha-ergocryptine (CB-154). Lloyd SJ, Josimovich JB, Archer DF. Am J Obstet Gynecol; 1975 May 01; 122(1):85-9. PubMed ID: 1168997 [Abstract] [Full Text] [Related]
3. Inhibition of cyclic gonadotropin secretion by endogenous human prolactin. Tyson JE, Khojandi M, Huth J, Smith B, Thomas P. Am J Obstet Gynecol; 1975 Feb 01; 121(3):375-9. PubMed ID: 1115151 [Abstract] [Full Text] [Related]
5. Use of brom-ergocryptine in treating amenorrhea/galactorrhea. Shapiro AG. South Med J; 1977 Jun 01; 70(6):720-1, 725. PubMed ID: 577621 [Abstract] [Full Text] [Related]
7. [Two cases of amenorrhea-galactorrhea with sterility treated with CB 154 (2 bromo-alpha-ergocryptine): ovulation and pregnancy]. Netter A, Netter AL, Gorins A. Gynecologie; 1975 Jun 01; 26(2):141-5. PubMed ID: 1164955 [No Abstract] [Full Text] [Related]
8. Hyperprolactinemic primary amenorrhea: case report with successful prolactin-lowering treatment and review of the literature. Farrari C, Telloli P, Rampini P, Caldara R. Gynecol Obstet Invest; 1980 Jun 01; 11(6):317-26. PubMed ID: 6785158 [Abstract] [Full Text] [Related]
9. Treatment of galactorrhea-amenorrhea syndrome with 2-Br-alpha-ergocryptin (CB 154). Clinical response and pattern of pituitary and steriod hormones before and during therapy. Künzig HJ, Geiger W, Schulz KD, Lose KH. Arch Gynakol; 1975 Jun 01; 218(2):85-94. PubMed ID: 1174026 [Abstract] [Full Text] [Related]
10. [2-bromo-alpha-ergocryptine in the treatment of luteal insufficiency]. Nappi C, Votino F, Mattera P, Montemagno U. Minerva Ginecol; 1979 Apr 01; 31(4):273-80. PubMed ID: 572516 [No Abstract] [Full Text] [Related]
11. Clinical response to CB-154 and the pituitary response to thyrotropin-releasing hormone-gonadotropin-releasing hormone in patients with galactorrhea-amenorrhea. March CM, Kletzky OA, Davajan V. Fertil Steril; 1977 May 01; 28(5):521-5. PubMed ID: 404198 [Abstract] [Full Text] [Related]
12. Bromocryptine therapy in cases of amenorrhea-galactorrhea. Mroueh AM, Siler-Khodr TM. Am J Obstet Gynecol; 1977 Feb 01; 127(3):291-8. PubMed ID: 576372 [Abstract] [Full Text] [Related]
17. Restoration of ovarian function by low nocturnal single daily doses of bromocriptine in patients with the galactorrhea-amenorrhea syndrome. de Bernal M, de Villamizar M. Fertil Steril; 1982 Mar 01; 37(3):392-6. PubMed ID: 6800849 [Abstract] [Full Text] [Related]
18. Editorial: Galactorrhea-amenorrhea, brom-ergocryptine, and the dopamine receptor. Boyd AE, Reighlin S. N Engl J Med; 1975 Aug 28; 293(9):451-2. PubMed ID: 1171365 [No Abstract] [Full Text] [Related]
19. 2alpha-bromoergocryptine in the management of the amenorrhea-galactorrhea syndrome. Clinical and endocrinological evaluation of response to treatment. Barreca P, Giannola C, Palisi F. Acta Eur Fertil; 1978 Mar 28; 9(1):21-9. PubMed ID: 567920 [No Abstract] [Full Text] [Related]